Chinese Community Smoking Cessation Project

This study has been completed.
Sponsor:
Collaborator:
Information provided by:
University of California, San Francisco
ClinicalTrials.gov Identifier:
NCT00139516
First received: August 29, 2005
Last updated: March 11, 2014
Last verified: March 2014
  Purpose

The study has two objectives/aims:

Aim 1: To test the efficacy of the intervention among adult smokers with cardiovascular disease, pulmonary disease and diabetes mellitus related illnesses (later modified to Chinese adults with and without diseases); and

Aim 2: To examine a set of measures (background, general health, psychosocial, and smoking process) that are associated with smoking cessation at 6 and 12 months


Condition Intervention
Cardiovascular Diseases
Heart Diseases
Lung Diseases
Diabetes Mellitus
Chronic Obstructive Pulmonary Disease
Behavioral: self-help
Drug: nicotine replacement therapy
Behavioral: smoking cessation

Study Type: Interventional
Study Design: Allocation: Randomized
Primary Purpose: Prevention

Resource links provided by NLM:


Further study details as provided by University of California, San Francisco:

Study Start Date: September 2001
Study Completion Date: August 2007
Primary Completion Date: August 2007 (Final data collection date for primary outcome measure)
  Show Detailed Description

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • having smoked a cigarette, cigar, or tobacco pipe during the 3 months preceding the baseline interview
  • reside in the San Francisco Bay Area at baseline
  • must be fluent in either English or Chinese (Mandarin or Cantonese)
  • be 18 and over in age and
  • not currently engaging in assisted smoking cessation efforts

Exclusion criteria

  • unable to speak English or Chinese
  • too ill to participate, or not willing to participate in smoking cessation effort
  • pregnancy
  • major psychiatric illness not under control/treatment
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00139516

Sponsors and Collaborators
University of California, San Francisco
Investigators
Investigator: Candice Wong University of California at San Francisco
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00139516     History of Changes
Other Study ID Numbers: 247, R01HL069363
Study First Received: August 29, 2005
Last Updated: March 11, 2014
Health Authority: United States: Federal Government

Additional relevant MeSH terms:
Cardiovascular Diseases
Diabetes Mellitus
Heart Diseases
Lung Diseases
Respiration Disorders
Pulmonary Disease, Chronic Obstructive
Lung Diseases, Obstructive
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases
Respiratory Tract Diseases
Nicotine
Ganglionic Stimulants
Autonomic Agents
Peripheral Nervous System Agents
Physiological Effects of Drugs
Pharmacologic Actions
Nicotinic Agonists
Cholinergic Agonists
Cholinergic Agents
Neurotransmitter Agents
Molecular Mechanisms of Pharmacological Action

ClinicalTrials.gov processed this record on April 23, 2014